Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of roflumilast in the treatment of psoriasis – a randomised controlled trial
2020-000711-76Phase 2Completed
- Sponsor
- Alexander Egeberg
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of roflumilast in plaque psoriasis (2 arms), sponsored by Alexander Egeberg. Primary endpoint: PASI75 at week 12. Started Mar 2020; status: completed.
02
Drugs
roflumilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2020-000711-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000711-76.